Insider Stock Trading History of Klausner Richard


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Klausner Richard since year 2005. The trader's CIK number is 1591178. At the time of this reporting, Klausner Richard is the Director of Juno Therapeutics, Inc. . (stock ticker symbol JUNO). See this page for all insider trading activities at Juno Therapeutics, Inc. .

Note that in the past Klausner Richard also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Klausner Richard since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-08 JUNO Juno Therapeutics, Inc. Sale 12,724 48.24 613,843
2017-12-21 JUNO Juno Therapeutics, Inc. Sale 36,000 44.94 1,617,876
2017-09-07 JUNO Juno Therapeutics, Inc. Sale 12,000 42.95 515,436
2017-08-07 JUNO Juno Therapeutics, Inc. Sale 12,000 30.34 364,092
2017-07-07 JUNO Juno Therapeutics, Inc. Sale 24,000 29.69 712,512
2017-06-07 JUNO Juno Therapeutics, Inc. Sale 24,000 23.73 569,616
2016-06-24 JUNO Juno Therapeutics, Inc. Sale 12,000 40.71 488,496
2016-05-18 JUNO Juno Therapeutics, Inc. Sale 12,000 40.00 480,000
2016-04-15 JUNO Juno Therapeutics, Inc. Sale 12,000 43.15 517,740
2016-03-22 JUNO Juno Therapeutics, Inc. Sale 12,000 40.00 480,000
2016-03-02 JUNO Juno Therapeutics, Inc. Sale 24,000 40.80 979,320
2015-12-15 JUNO Juno Therapeutics, Inc. Sale 12,000 45.72 548,688
2015-11-13 ILMN Illumina Inc Sale 730 163.52 119,369
2015-11-13 JUNO Juno Therapeutics, Inc. Sale 12,000 49.83 597,960
2015-10-15 JUNO Juno Therapeutics, Inc. Sale 8,000 50.00 400,000
2015-10-12 JUNO Juno Therapeutics, Inc. Sale 16,000 50.00 800,016
2015-09-28 ILMN Illumina Inc Sale 423 173.20 73,263
2015-07-15 JUNO Juno Therapeutics, Inc. Sale 8,000 53.64 429,096
2015-06-23 JUNO Juno Therapeutics, Inc. Sale 8,000 52.38 419,008
2015-03-10 ILMN Illumina Inc Sale 1,186 191.75 227,415

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Klausner Richard (Director of Juno Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.